SC 13G Filing

Company

Crinetics Pharmaceuticals, Inc.

Filed

March 11, 2024

Accession Number

0000935836-24-000281

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →